BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 6327014)

  • 1. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
    Milas L; McBride WH; Hunter N; Ito H
    Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation-induced leg contractures in mice.
    Hunter N; Milas L
    Cancer Res; 1983 Apr; 43(4):1630-2. PubMed ID: 6831410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Milas L; Hunter N; Stephens LC; Peters LJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
    Gasic GJ; Iwakawa A; Gasic TB; Viner ED; Milas L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5670-6. PubMed ID: 6498828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
    Milas L; Hersh EM; Stringfellow DA; Hunter N
    J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
    Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine.
    Paunesku D; Paunesku T; Wahl A; Kataoka Y; Murley J; Grdina DJ; Woloschak GE
    Int J Radiat Biol; 2008 Aug; 84(8):623-34. PubMed ID: 18661379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimutagenic effects of amifostine: clinical implications.
    Kataoka Y; Perrin J; Hunter N; Milas L; Grdina DJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):53-7. PubMed ID: 8783668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice.
    Chu AM; Fowler JF
    Cancer Res; 1982 May; 42(5):1943-9. PubMed ID: 7066905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of delayed-type hypersensitivity to oxazolone in whole-body-irradiated mice and protection by WR-2721.
    Srinivasan V; Weiss JF
    Radiat Res; 1984 Jun; 98(3):438-44. PubMed ID: 6328568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
    Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
    Murray D; Altschuler EM; Hunter N; Milas L
    Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D; Bensely D; Schein P
    Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug combination against single drug treatment in radiation protection of the bone marrow CFU.
    Bisht KS; Uma Devi P; Jagetia GC; Kamath G
    Strahlenther Onkol; 1990 Aug; 166(8):545-8. PubMed ID: 2168583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low doses of whole body irradiation on spontaneous lung metastasis of NFSA2ALM1 mouse tumors.
    Suzuki N; Mizukoshi T
    Radiat Med; 1987; 5(6):212-4. PubMed ID: 3330828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioprotective effect of combinations of WR-2721 and mercaptopropionylglycine on mouse bone marrow chromosomes.
    Uma Devi P; Prasanna PG
    Radiat Res; 1990 Nov; 124(2):165-70. PubMed ID: 2174174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.